Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Human Papillomavirus Type 16”

233 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 233 results

Testing effectiveness (Phase 2)UnknownNCT04398524
What this trial is testing

A Phase II Study of Cemiplimab and ISA101b in Patients With Recurrent/Metastatic HPV16 Positive OPC

Who this might be right for
Squamous Cell Carcinoma of the Oropharynx
ISA Pharmaceuticals 65
Very early researchEnded earlyNCT04630353
What this trial is testing

A Study HB-201 in Patients With Newly Diagnosed HPV16+ Oropharynx or Locally Advanced Cervical Cancer

Who this might be right for
HPV 16+ Confirmed Oropharynx Cancer and Cervical Cancer
Hookipa Biotech GmbH 10
Large-scale testing (Phase 3)Study completedNCT00306241
What this trial is testing

Evaluate the Immunogenicity and Safety of GSK Biologicals' HPV Vaccine in Healthy Women Aged 18-35 Years

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline 300
Testing effectiveness (Phase 2)Study completedNCT04646005
What this trial is testing

Cemiplimab and ISA101b Vaccine in Adult Participants With Recurrent/Metastatic Human Papillomavirus (HPV)16 Cervical Cancer Who Have Experienced Disease Progression After First Line Chemotherapy

Who this might be right for
Cervical Cancer
Regeneron Pharmaceuticals 113
Early research (Phase 1)Study completedNCT00257738
What this trial is testing

0804 GCC: MAGE-A3/HPV 16 Vaccine for Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Squamous Cell Carcinoma of the Head and Neck
University of Maryland, Baltimore 17
Early research (Phase 1)Active Not RecruitingNCT05973487
What this trial is testing

A Basket Study of Customized Autologous TCR-T Cell Therapies in Patients With Locally Advanced (Unresectable) or Metastatic Solid Tumors

Who this might be right for
Head and Neck CancerCervical CancerNon-small Cell Carcinoma+18 more
TScan Therapeutics, Inc. 840
Large-scale testing (Phase 3)Study completedNCT00316706
What this trial is testing

Human Papilloma Virus (HPV) Vaccine Trial in Young Adolescent Women With GlaxoSmithKline Biologicals' (GSK Bio) HPV-16/18 Vaccine

Who this might be right for
Cervical Intraepithelial NeoplasiaPapillomavirus Infection
GlaxoSmithKline 1,245
Testing effectiveness (Phase 2)Looking for participantsNCT06319963
What this trial is testing

Evaluate Lenti-HPV-07 Immunotherapy Against HPV+ Cervical or Oropharyngeal Cancer

Who this might be right for
HPV-Related Cervical CarcinomaHPV Positive Oropharyngeal Squamous Cell Carcinoma
Theravectys S.A. 72
Early research (Phase 1)Ended earlyNCT04762225
What this trial is testing

RPTR-168 in Patients With Human Papillomavirus Strain 16 (HPV-16) E6/E7 Positive Tumors and Melanoma

Who this might be right for
Head and Neck Squamous Cell CarcinomaMelanomaCervical Cancer
Repertoire Immune Medicines 7
Testing effectiveness (Phase 2)Active Not RecruitingNCT04369937
What this trial is testing

HPV-16 Vaccination and Pembrolizumab Plus Cisplatin for "Intermediate Risk" HPV-16-associated Head and Neck Squamous Cell Carcinoma

Who this might be right for
HPV-Related Squamous Cell CarcinomaHead and Neck Squamous Cell Carcinoma
Dan Zandberg 18
Not applicableStudy completedNCT01101542
What this trial is testing

Evaluation of Safety of a Vaccine Against Cervical Cancer in Healthy Korean Females

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline 3,091
Early research (Phase 1)Ended earlyNCT03815682
What this trial is testing

RPTR-147 in Patients With Selected Solid Tumors and Lymphomas

Who this might be right for
Solid TumorLymphoma
Repertoire Immune Medicines 23
Early research (Phase 1)Looking for participantsNCT04131413
What this trial is testing

HPV DNA Vaccine Via Electroporation for HPV16 Positive Cervical Neoplasia

Who this might be right for
Human Papillomavirus Type 16Cervical Intraepithelial Neoplasia Grade IICervical Intraepithelial Neoplasia, Grade III
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 48
Large-scale testing (Phase 3)Study completedNCT00092534
What this trial is testing

Cervical Intraepithelial Neoplasm (CIN) in Women (Gardasil) (V501-015)

Who this might be right for
Cervical CancerGenital Warts
Merck Sharp & Dohme LLC 12,167
Not applicableActive Not RecruitingNCT00867464
What this trial is testing

Extended Follow Up of Young Women in Costa Rica Who Received Vaccine for Human Papillomavirus Types 16 and 18 and Unvaccinated Controls

Who this might be right for
Anal CarcinomaCervical CarcinomaHuman Papillomavirus Infection+2 more
National Cancer Institute (NCI) 8,670
Testing effectiveness (Phase 2)Study completedNCT03180684
What this trial is testing

Evaluation of VGX-3100 and Electroporation Alone or in Combination With Imiquimod for the Treatment of HPV-16 and/or HPV-18 Related Vulvar HSIL (Also Referred as: VIN 2 or VIN 3)

Who this might be right for
Vulvar High Grade Squamous Intraepithelial Lesion (HSIL)Vulvar DysplasiaVulvar Intraepithelial Neoplasia (VIN)+4 more
Inovio Pharmaceuticals 33
Testing effectiveness (Phase 2)Study completedNCT04405349
What this trial is testing

Investigating the Combination of VB10.16 and Atezolizumab in Patients With HPV 16-positive Cervical Cancer

Who this might be right for
Cervical CancerCervix Cancer
Nykode Therapeutics ASA 52
Not applicableStudy completedNCT02558803
What this trial is testing

HPV Vaccination: Evaluation of Reminder Prompts for Doses 2 & 3

Who this might be right for
Human Papilloma Virus Infection Type 11Human Papilloma Virus Infection Type 16Human Papilloma Virus Infection Type 18+4 more
Regenstrief Institute, Inc. 1,305
Large-scale testing (Phase 3)Study completedNCT03185013
What this trial is testing

REVEAL 1 (Evaluation of VGX-3100 and Electroporation for the Treatment of Cervical HSIL)

Who this might be right for
Cervical DysplasiaCervical High Grade Squamous Intraepithelial LesionHSIL
Inovio Pharmaceuticals 201
Not applicableActive Not RecruitingNCT06243666
What this trial is testing

Long-term Effectiveness and Immuno-persistence Study of a Recombinant HPV 16/18 Bivalent Vaccine in Preadolescent Girls

Who this might be right for
Cervical Intraepithelial NeoplasiaCervical CancerPersistent Infection
Xiamen University 2,188
Load More Results